Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMXA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $123,062
Award facts
- Contract value 100% obligated
- $123,062.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $123,062.25 to DMS Pharmaceutical Group Inc. for Keytruda (pembrolizumab) 100 mg/4 mL vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this delivery order with an ultimate completion date of October 6, 2025. This award carries no set-aside designation, and the place of performance is located in Park Ridge, Illinois. The contract represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders from the Defense Logistics Agency for branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare operations. The company's portfolio of prior awards demonstrates expertise in delivering specialized pharmaceutical products including oncology treatments, vaccines, and auto-injectors to military medical facilities nationwide. This Keytruda delivery order aligns with the contractor's core competency in providing premium pharmaceutical products directly to federal healthcare systems and reinforces its positioning as a reliable distributor of prescription medications for defense health support missions.
Quick answers
Who was awarded contract SPE2DB25FNMXA?
SPE2DB25FNMXA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNMXA worth?
The government has obligated $123,062 on SPE2DB25FNMXA.
Is contract SPE2DB25FNMXA an order under another contract?
Yes. SPE2DB25FNMXA is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMXA competed?
The extent of competition for SPE2DB25FNMXA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award